| __timestamp | Dr. Reddy's Laboratories Limited | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12402000000 | 19586000 |
| Thursday, January 1, 2015 | 17449000000 | 29135000 |
| Friday, January 1, 2016 | 17834000000 | 42791000 |
| Sunday, January 1, 2017 | 19551000000 | 49577000 |
| Monday, January 1, 2018 | 18265000000 | 89209000 |
| Tuesday, January 1, 2019 | 15607000000 | 69099000 |
| Wednesday, January 1, 2020 | 15410000000 | 75961000 |
| Friday, January 1, 2021 | 16541000000 | 90467000 |
| Saturday, January 1, 2022 | 17482000000 | 74552000 |
| Sunday, January 1, 2023 | 19381000000 | 91593000 |
| Monday, January 1, 2024 | 22873000000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Dr. Reddy's Laboratories Limited and Supernus Pharmaceuticals, Inc. have shown distinct strategies in their R&D allocations over the past decade. From 2014 to 2023, Dr. Reddy's consistently invested heavily in R&D, with expenditures peaking at approximately 22.9 billion in 2024, marking an impressive 84% increase from 2014. In contrast, Supernus Pharmaceuticals, Inc. demonstrated a more modest growth trajectory, with R&D expenses rising from around 19.6 million in 2014 to 91.6 million in 2023, a nearly fivefold increase. This disparity highlights the different scales and strategies of these companies, with Dr. Reddy's focusing on expansive growth and Supernus on targeted innovation. Notably, data for Supernus in 2024 is missing, suggesting potential shifts in strategy or reporting.
R&D Spending Showdown: Zoetis Inc. vs Dr. Reddy's Laboratories Limited
Research and Development Expenses Breakdown: Dr. Reddy's Laboratories Limited vs Apellis Pharmaceuticals, Inc.
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Perrigo Company plc
Dr. Reddy's Laboratories Limited or Supernus Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
R&D Insights: How Dr. Reddy's Laboratories Limited and BioCryst Pharmaceuticals, Inc. Allocate Funds
R&D Spending Showdown: Bio-Techne Corporation vs Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: TG Therapeutics, Inc. and Supernus Pharmaceuticals, Inc.
Research and Development Investment: Bausch Health Companies Inc. vs Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. vs Mesoblast Limited: Strategic Focus on R&D Spending
R&D Spending Showdown: Supernus Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
Who Prioritizes Innovation? R&D Spending Compared for Supernus Pharmaceuticals, Inc. and Evotec SE
Comparing Innovation Spending: Supernus Pharmaceuticals, Inc. and Travere Therapeutics, Inc.